Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CHORIOGONADOTROPIN ALFA for Weight control: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where CHORIOGONADOTROPIN ALFA was used for Weight control.

Most Reported Side Effects for CHORIOGONADOTROPIN ALFA

Side Effect Reports % Deaths Hosp.
Ovarian hyperstimulation syndrome 1,016 37.3% 12 816
Ascites 261 9.6% 0 243
No adverse event 200 7.4% 0 0
Abdominal pain 169 6.2% 1 136
Drug ineffective 161 5.9% 3 25
Abdominal distension 160 5.9% 0 121
Dyspnoea 144 5.3% 4 128
Off label use 139 5.1% 4 53
Nausea 113 4.2% 0 76
Product dose omission issue 100 3.7% 0 0
Pleural effusion 90 3.3% 1 77
Inappropriate schedule of drug administration 83 3.1% 0 1
Product use in unapproved indication 83 3.1% 2 25
Product packaging quantity issue 80 2.9% 0 0
Abortion spontaneous 75 2.8% 0 8

Other Indications for CHORIOGONADOTROPIN ALFA

Ovulation induction (460) In vitro fertilisation (396) Assisted reproductive technology (345) Product used for unknown indication (228) Assisted fertilisation (153) Infertility female (119) Infertility (118) Controlled ovarian stimulation (75) Weight decreased (38) Testicular failure (34)

Other Drugs Used for Weight control

TIRZEPATIDE (17,354) SEMAGLUTIDE (6,378) BUPROPION\NALTREXONE (2,842) LIRAGLUTIDE (1,046) LORCASERIN (243) ORLISTAT (235) DULAGLUTIDE (180) PHENTERMINE (79) TOPIRAMATE (65) BELVIQ (58)

Related Pages

CHORIOGONADOTROPIN ALFA Full Profile All Weight control Drugs CHORIOGONADOTROPIN ALFA Demographics CHORIOGONADOTROPIN ALFA Timeline